American Renal Associates Holdings, Inc. Announces Settlement of Shareholder Derivative Litigation
(WorldNews Business)

BEVERLY, Mass.--(BUSINESS WIRE)--Sep 18, 2020-- American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading provider of outpatient dialysis services, is pleased to announce that the Company has received preliminary approval of the settlement of a stockholder derivative action brought by Plaintiff Luke Johnson, and pending in the United States District Court for the District of New Jersey (case number No. 19-cv-15812) (the “Johnson Action”). The proposed settlement releases all claims asserted against the Company and the other named defendants in the Johnson Action...